ZA202206078B
(en )
2023-11-29
Anti-cd3 antibodies and methods of use
EA201790664A1
(en )
2017-07-31
ANTIBODIES AGAINST MEZOTELINE AND IMMUNOCONJUGATES
MX2013011479A
(en )
2013-11-04
Anti-fgfr4 antibodies and methods of use.
PH12015502565B1
(en )
2016-02-29
Anti-transferrin receptor antibodies and methods of use
MX346500B
(en )
2017-03-22
Methods and compositions for neural disease immunotherapy.
MY178142A
(en )
2020-10-05
Anti-phf-tau antibodies and their uses
NZ604510A
(en )
2013-10-25
Dilutable biocidal compositions and methods of use
MX2014004022A
(en )
2014-04-30
ANTI-HtrA1 ANTIBODIES AND METHODS OF USE.
MX2013007168A
(en )
2013-11-04
Anti-pcsk9 antibodies and methods of use.
MX2013001473A
(en )
2013-04-29
Antibodies against il-18r1 and uses thereof.
MX2013005793A
(en )
2013-07-22
Low affinity blood brain barrier receptor antibodies and uses therefor.
MX2015013901A
(en )
2015-12-11
Anti-il-4 antibodies and bispecific antibodies and uses thereof.
MX336682B
(en )
2016-01-27
Antibodies against human csf-1r and uses thereof.
MX2014002053A
(en )
2014-04-25
Anti-mcsp antibodies.
EP2566890A4
(en )
2013-11-20
Anti-pai-1 antibodies and methods of use thereof
PH12015501059A1
(en )
2015-07-27
Anti-hemagglutinin antibodies and methods of use
MX336323B
(en )
2016-01-15
Anti-polyubiquitin antibodies and methods of use.
PH12014501605A1
(en )
2014-10-08
Anti-lrp5 antibodies and methods of use
MX2013002960A
(en )
2013-05-09
Antibody compositions and methods of use.
MX2014014381A
(en )
2015-02-05
Anti-theophylline antibodies and methods of use.
UA109148C2
(en )
2015-07-27
Compositions based on anti-vegfr-3 antibody
NZ743625A
(en )
2022-11-25
Human oncostatin m antibodies and methods of use
MX2015004892A
(en )
2015-11-16
Methods and compositions relating to anti-il-21 receptor antibodies.
GB201021909D0
(en )
2011-02-02
Multi-analyte microarrays using tag-specific antibodies and tag-anchored antibodies
MA39078B1
(en )
2020-03-31
Anti-cd3 antibodies and methods of use